At the end of Q3 2024, shares of Tilray Brands, Inc. (NASDAQ:TLRY) were held by 16 hedge funds in the IM database with a total stake value of $20.62 million, up 36% from the previous quarter.

Tilray cultivates a wide range of strains to meet patient needs including indicas, sativas, hybrids, and CBD-rich varieties. Medical cannabis is available in two primary forms: extracts and dried ...

Tilray Brands Inc.’s stock fell Friday after the beer and cannabis company said it expects a $20 million impact on its full-year revenue as it embarks on a cost-cutting plan that will reduce the ...